Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization

Koksal N., Altinkaya N., Perk Y.

ACTA PAEDIATRICA, cilt.85, sa.12, ss.1501-1502, 1996 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 85 Sayı: 12
  • Basım Tarihi: 1996
  • Doi Numarası: 10.1111/j.1651-2227.1996.tb13961.x
  • Dergi Adı: ACTA PAEDIATRICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1501-1502
  • Anahtar Kelimeler: HBsAg antigenemia, hepatitis vaccine, newborn, IMMUNOGENICITY, VACCINE, SAFETY
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Following immunization with hepatitis B vaccine, 39 infants were followed prospectively for hepatitis B surface antigen (HBsAg). A total of 69.2% of the infants tested positive for antigenemia at least once. Antigenemia was identified most often at 2-3 days (43.5%) and 5-6 days (43.5%) after immunization. The longest documented duration of antigenemia was 21 days. In all cases the antigenemia was transient and cleared by the 28th day post-vaccination.